World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
13989
World Ranking
3943
National Ranking
1806

Overview

Dennis Panicali is affiliated with Harvard University in the United States. The available data does not provide detailed records of research papers, co-authors, or specific publication venues linked to their work.

There are no listed recent papers including titles, years of publication, or venues for Dennis Panicali. Similarly, no frequent co-authors or publication venues are indicated in the records.

The profile does not show information concerning book publications, so it is unclear if Panicali has contributed to academic books or monographs.

No specific main fields or subfields of study are available, nor are there clearly defined main research topics attributed to Dennis Panicali based on the data.

No awards or honors are documented in the provided information.

As current records indicate, Dennis Panicali is living and active in their academic role, though detailed visibility into their research output or scholarly impact is limited based on this data.

Best Publications

  • Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

    Harry W. Kestier;Douglas J. Ringler;Kazuyasu Mori;Dennis L. Panicali

  • Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

    Philip W. Kantoff;Thomas J. Schuetz;Brent A. Blumenstein;L. Michael Glode

  • High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

    C Rinaldo;X L Huang;Z F Fan;M Ding

  • Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.

    H L Robinson;D C Montefiori;R P Johnson;K H Manson

  • Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity

    Dan H. Barouch;Maria G. Pau;Jerome H. H. V. Custers;Wouter Koudstaal

  • A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

    Joseph Paul Eder;Philip W. Kantoff;Kristin Roper;GuangXian Xu

  • Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing Carcinomas

    John L. Marshall;James L. Gulley;Philip M. Arlen;Patricia K. Beetham

  • Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.

    Dennis Panicali;Stephen W. Davis;Randall L. Weinberg;Enzo Paoletti

  • A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

    Philip M Arlen;James L Gulley;Catherine Parker;Lisa Skarupa

  • Recombinant pox virus for immunization against tumor-associated antigens

    Jeffrey Schlom;Judith Kantor;Donald Kufe;Dennis Panicali

  • Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.

    Michael Wang;Vincenzo Bronte;Pauline W. Chen;Linda Gritz

  • Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

    Elke Jäger;Julia Karbach;Sacha Gnjatic;Antje Neumann

  • Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.

    James Gulley;Alice P. Chen;William Dahut;Philip M. Arlen

  • Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

    Martin G. Sanda;Martin G. Sanda;David C. Smith;Linda G. Charles;Clara Hwang

  • Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL

    J L Chen;P R Dunbar;U Gileadi;E Jäger

  • HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.

    K Luzuriaga;D Holmes;A Hereema;J Wong

  • Molecular genetics of vaccinia virus: demonstration of marker rescue

    Eileen Nakano;Dennis Panicali;Enzo Paoletti

  • Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.

    Rene Bernards;Antoinette Destree;Sara McKenzie;Ethel Gordon

  • Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma

    Howard L. Kaufman;Gail DeRaffele;Josephine Mitcham;Dorota Moroziewicz

  • Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant

    Erik Kass;Dennis L. Panicali;Gail Mazzara;Jeffrey Schlom

Frequent Co-Authors

Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
James L. Gulley
James L. Gulley National Institutes of Health
John L. Sullivan
John L. Sullivan University of Massachusetts Chan Medical School
Philip M. Arlen
Philip M. Arlen National Institutes of Health
Kwong Y. Tsang
Kwong Y. Tsang National Institutes of Health
Sampa Santra
Sampa Santra Beth Israel Deaconess Medical Center
David C. Montefiori
David C. Montefiori Duke University
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Enzo Paoletti
Enzo Paoletti Rensselaer Polytechnic Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare career paths, many of which can be pursued through flexible online programs. For those looking to enter nursing without prior experience, exploring online adn programs for non nurses can be an excellent starting point. These programs provide foundational skills essential for patient care and immunology-related fields.

For quicker entry into the nursing profession, accelerated routes like the easiest absn program to get into offer a streamlined path for individuals who already hold a degree in another discipline. This option allows for fast-tracking essential nursing education without sacrificing quality.

Additionally, those seeking practical nursing roles may find that exploring which lpn programs are easiest to get into provides valuable insight into accessible programs that can lead to rewarding careers supporting immunology-related healthcare services.

For advanced practice and leadership in immunology and healthcare, many turn to easiest online nurse practitioner programs. These flexible degrees allow professionals to specialize further, often focusing on immunology, infectious diseases, or related fields, enhancing career growth and impact.

Best Scientists Citing Dennis Panicali